Researchers and institutions in Germany and the UK dominate in the starting grants for independent research issued by the recently created European Research Council.
Alexander von Gabain and his team laid the foundations of an enterprise that would rise to the top of the continent’s biotechnology pile – and rewrite the region’s rules for biotechnology start-ups.
The spin-out tag makes university start-ups look weak and vulnerable, says Philip Sharpe from QinetiQ, one of Europe’s largest technology commercialisation companies.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.